- Projects & figures
- News & Events
- Managing your project
- About ERC
Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.
A project funded by the ERC developed an innovative and comprehensive framework to study energy poverty in Europe. It also produced evidence applicable beyond academia, laying ground for the EU’s Energy Poverty Observatory set up in 2018.
Cities and regions around the world are increasingly inter-connected. One clear factor for this connectivity is foreign investment: the flow of capital, skills and knowledge that can – under the right circumstances - "bless" an area, improving its economic and social standing. ERC grantee Riccardo Crescenzi studies where these flows are concentrated, how different actors choose where to invest and what are their impacts on both the home and host economies.
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
Teaching is certainly one of the most important professions in our society, yet its status and attractiveness have been systematically diminishing in the last decades. At the Université catholique de Louvain, Prof. Xavier Dumay is using his ERC Starting Grant to investigate the cultural and institutional transformations that have led to this "teaching profession crisis".
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
More than 100 million people worldwide suffer from valvular heart disease, affecting one or more of the heart’s four valves and causing breathlessness, chest pain, dizziness and fainting. If severe valvular heart disease is not properly treated, chances of surviving decrease, especially in the elderly. The only effective therapy is heart valve replacement, which may entail some risks and lead to revision surgeries. What can be done to improve safety and durability of artificial heart valves?
Based on University of Turku's press release
For more than 3000 years, men have captured wild Asian elephants to use them for work or entertainment. In a new study published today in Nature Communications, ERC grantee Virpi Lummaa shows the harmful effects of these ongoing practices on wild-caught animals. The findings are based on detailed records from the past 100 years over a population of 5000 timber elephants from Myanmar.
CRISPR is a widely used molecular biology tool exploiting an immune process discovered in bacteria. Dr David Bikard studies CRISPR in bacterial cells, in conjunction with different DNA repair systems, to create even newer tools. He hopes to gain insight into bacterial genetics, and develop increasingly effective medical treatments.
Cell transplantation is a promising new approach for organ regeneration in disease or after injury. To support the differentiation of hepatocytes from stem cells, European researchers developed ex vivo organoids which precisely mimic liver architecture.